Home / Inspections / 1073148

FDA Inspection 1073148 — Northwind Pharmaceuticals LLC

Northwind Pharmaceuticals LLC — FEI 1831143

The FDA completed an inspection of Northwind Pharmaceuticals LLC on November 16, 2018 in Indianapolis, IN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 16, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Indianapolis, IN (United States)

Facility

Other inspections at this facility

  • 1256379 (VAI Fri Sep 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1011451 (NAI Mon Mar 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 952157 (OAI Wed Dec 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 944649 (VAI Mon Sep 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 900116 (NAI Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources